Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Preparation of a Reference Material for the Determination of Hexavalent Chromium in Tap Water.

Inui T, Shirota H, Sakao S.

Anal Sci. 2019 Aug 30. doi: 10.2116/analsci.19P259. [Epub ahead of print] No abstract available.

2.

Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis.

Sakao S, Tanabe N, Tatsumi K.

J Am Heart Assoc. 2019 Aug 20;8(16):e013310. doi: 10.1161/JAHA.119.013310. Epub 2019 Aug 19. No abstract available.

3.

Protective role of endothelial progenitor cells stimulated by riociguat in chronic thromboembolic pulmonary hypertension.

Yamamoto K, Nishimura R, Kato F, Naito A, Suda R, Sekine A, Jujo T, Shigeta A, Sakao S, Tanabe N, Tatsumi K.

Int J Cardiol. 2019 Jul 15. pii: S0167-5273(19)30981-7. doi: 10.1016/j.ijcard.2019.07.017. [Epub ahead of print]

4.

The updated classification of PVOD/PCH: A slight but meaningful change.

Sakao S.

Respir Investig. 2019 Sep;57(5):408-409. doi: 10.1016/j.resinv.2019.04.001. Epub 2019 May 15. No abstract available.

PMID:
31103397
5.

Pulmonary hypertension with a low cardiac index requires a higher PaO2 level to avoid tissue hypoxia.

Suda R, Tanabe N, Terada J, Naito A, Kasai H, Nishimura R, Sanada TJ, Sugiura T, Sakao S, Tatsumi K.

Respirology. 2019 May 16. doi: 10.1111/resp.13574. [Epub ahead of print]

PMID:
31099121
6.

Chronic obstructive pulmonary disease and the early stage of cor pulmonale: A perspective in treatment with pulmonary arterial hypertension-approved drugs.

Sakao S.

Respir Investig. 2019 Jul;57(4):325-329. doi: 10.1016/j.resinv.2019.03.013. Epub 2019 May 10. Review.

PMID:
31085118
7.

Chronic thromboembolic pulmonary hypertension in Austria and Japan.

Chausheva S, Naito A, Ogawa A, Seidl V, Winter MP, Sharma S, Sadushi-Kolici R, Campean IA, Taghavi S, Moser B, Klepetko W, Ishida K, Matsubara H, Sakao S, Lang IM.

J Thorac Cardiovasc Surg. 2019 Aug;158(2):604-614.e2. doi: 10.1016/j.jtcvs.2019.01.019. Epub 2019 Jan 21.

PMID:
31084984
8.

Involvement of pulmonary arteriopathy in the development and severity of reperfusion pulmonary edema after pulmonary endarterectomy.

Sanada TJ, Tanabe N, Ishibashi-Ueda H, Ishida K, Naito A, Sakao S, Suda R, Kasai H, Nishimura R, Sugiura T, Shigeta A, Taniguchi Y, Masuda M, Tatsumi K.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019846439. doi: 10.1177/2045894019846439.

9.

Characterization of pulmonary intimal sarcoma cells isolated from a surgical specimen: In vitro and in vivo study.

Sanada TJ, Sakao S, Naito A, Ishibashi-Ueda H, Suga M, Shoji H, Miwa H, Suda R, Iwasawa S, Tada Y, Ishida K, Tanabe N, Tatsumi K.

PLoS One. 2019 Mar 29;14(3):e0214654. doi: 10.1371/journal.pone.0214654. eCollection 2019.

10.

Single-use suvorexant for treating insomnia during overnight polysomnography in patients with suspected obstructive sleep apnea: a single-center experience.

Matsumura T, Terada J, Yoshimura C, Koshikawa K, Kinoshita T, Yahaba M, Nagashima K, Sakao S, Tatsumi K.

Drug Des Devel Ther. 2019 Feb 28;13:809-816. doi: 10.2147/DDDT.S197237. eCollection 2019.

11.

Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome.

Ohashi K, Nishimura R, Sugimoto S, Sakao S, Tanabe N, Tatsumi K.

Respirol Case Rep. 2019 Feb 27;7(4):e00411. doi: 10.1002/rcr2.411. eCollection 2019 May.

12.

Pulmonary Hypertension that Developed During Treatment for Hepatopulmonary Syndrome and Pulmonary Arteriovenous Malformation.

Ikubo Y, Kasai H, Sugiura T, Saito T, Shoji H, Sakao S, Kasahara Y, Tanabe N, Tatsumi K.

Intern Med. 2019 Jun 15;58(12):1765-1769. doi: 10.2169/internalmedicine.1993-18. Epub 2019 Feb 25.

13.

Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a concomitant psychiatric disorder.

Tajima H, Kasai H, Tanabe N, Sugiura T, Miwa H, Naito A, Suda R, Nishimura R, Sanada TJ, Sakao S, Tatsumi K.

Pulm Circ. 2019 Jan-Mar;9(1):2045894019836420. doi: 10.1177/2045894019836420.

14.

Elevated levels of autoantibodies against EXD2 and PHAX in the sera of patients with chronic thromboembolic pulmonary hypertension.

Naito A, Hiwasa T, Tanabe N, Sanada TJ, Sugiura T, Shigeta A, Terada J, Takizawa H, Kashiwado K, Sakao S, Tatsumi K.

PLoS One. 2019 Feb 13;14(2):e0211377. doi: 10.1371/journal.pone.0211377. eCollection 2019.

15.

Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor.

Naito A, Sakao S, Lang IM, Voelkel NF, Jujo T, Ishida K, Sugiura T, Matsumiya G, Yoshino I, Tanabe N, Tatsumi K.

BMC Pulm Med. 2018 Dec 29;18(1):197. doi: 10.1186/s12890-018-0769-3.

16.

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis.

Shimomura I, Abe M, Li Y, Tsushima K, Sakao S, Tanabe N, Ikusaka M, Tatsumi K.

Intern Med. 2019 Apr 1;58(7):965-968. doi: 10.2169/internalmedicine.1384-18. Epub 2018 Dec 18.

17.

Use of vasodilators for the treatment of pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: A systematic review.

Ogawa A, Sakao S, Tanabe N, Matsubara H, Tatsumi K.

Respir Investig. 2019 Mar;57(2):183-190. doi: 10.1016/j.resinv.2018.10.004. Epub 2018 Nov 23.

PMID:
30473253
18.

Safety of diagnostic flexible bronchoscopy in patients with echocardiographic evidence of pulmonary hypertension.

Ishiwata T, Abe M, Kasai H, Ikari J, Kawata N, Terada J, Sakao S, Tada Y, Tanabe N, Tatsumi K.

Respir Investig. 2019 Jan;57(1):73-78. doi: 10.1016/j.resinv.2018.08.009. Epub 2018 Oct 24.

PMID:
30366834
19.

Partial anomalous pulmonary venous return with dual drainage to the superior vena cava and left atrium with pulmonary hypertension.

Tanaka N, Jujo T, Sugiura T, Matsuura K, Kobayashi T, Naito A, Shimazu K, Kasai H, Suda R, Nishimura R, Ikari J, Sakao S, Tanabe N, Matsumiya G, Tatsumi K.

Respir Med Case Rep. 2018 Aug 7;25:112-115. doi: 10.1016/j.rmcr.2018.08.003. eCollection 2018.

20.

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: A systematic review.

Tanabe N, Kawakami T, Satoh T, Matsubara H, Nakanishi N, Ogino H, Tamura Y, Tsujino I, Ogawa A, Sakao S, Nishizaki M, Ishida K, Ichimura Y, Yoshida M, Tatsumi K.

Respir Investig. 2018 Jul;56(4):332-341. doi: 10.1016/j.resinv.2018.03.004. Epub 2018 Jul 3.

PMID:
30008295
21.

Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.

Matsumura T, Terada J, Kinoshita T, Sakurai Y, Yahaba M, Tsushima K, Sakao S, Nagashima K, Ozaki T, Kobayashi Y, Hiwasa T, Tatsumi K.

PLoS One. 2018 Mar 29;13(3):e0195015. doi: 10.1371/journal.pone.0195015. eCollection 2018.

22.

Long-Term Outcome of Chronic Thromboembolic Pulmonary Hypertension at a Single Japanese Pulmonary Endarterectomy Center.

Miwa H, Tanabe N, Jujo T, Kato F, Anazawa R, Yamamoto K, Naito A, Kasai H, Nishimura R, Suda R, Sugiura T, Sakao S, Ishida K, Masuda M, Tatsumi K.

Circ J. 2018 Apr 25;82(5):1428-1436. doi: 10.1253/circj.CJ-17-1242. Epub 2018 Mar 13.

23.

Impact of Arterial Stiffness on WatchPAT Variables in Patients With Obstructive Sleep Apnea.

Kinoshita T, Yahaba M, Terada J, Matsumura T, Sakurai Y, Nagashima K, Sakao S, Tatsumi K.

J Clin Sleep Med. 2018 Mar 15;14(3):319-325. doi: 10.5664/jcsm.6970.

24.

Heart Rate and Oxygen Saturation Change Patterns During 6-min Walk Test in Subjects With Chronic Thromboembolic Pulmonary Hypertension.

Inagaki T, Terada J, Yahaba M, Kawata N, Jujo T, Nagashima K, Sakao S, Tanabe N, Tatsumi K.

Respir Care. 2018 May;63(5):573-583. doi: 10.4187/respcare.05788. Epub 2017 Dec 26.

25.

Mosaic attenuation pattern in non-contrast computed tomography for the assessment of pulmonary perfusion in chronic thromboembolic pulmonary hypertension.

Kasai H, Tanabe N, Fujimoto K, Hoshi H, Naito J, Suzuki R, Matsumura A, Sugiura T, Sakao S, Tatsumi K.

Respir Investig. 2017 Sep;55(5):300-307. doi: 10.1016/j.resinv.2017.07.003. Epub 2017 Aug 24.

PMID:
28942885
26.

Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.

Kato F, Sakao S, Takeuchi T, Suzuki T, Nishimura R, Yasuda T, Tanabe N, Tatsumi K.

Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L899-L915. doi: 10.1152/ajplung.00527.2016. Epub 2017 Aug 10.

27.

Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor.

Yamamoto K, Tanabe N, Suda R, Sasaki A, Matsumura A, Ema R, Kasai H, Kato F, Sekine A, Nishimura R, Jujo T, Sugiura T, Shigeta A, Sakao S, Tatsumi K.

Respir Investig. 2017 Jul;55(4):270-275. doi: 10.1016/j.resinv.2017.04.004. Epub 2017 Jun 19.

PMID:
28705306
28.

The dilatation of main pulmonary artery and right ventricle observed by enhanced chest computed tomography predict poor outcome in inoperable chronic thromboembolic pulmonary hypertension.

Ema R, Sugiura T, Kawata N, Tanabe N, Kasai H, Nishimura R, Jujo T, Shigeta A, Sakao S, Tatsumi K.

Eur J Radiol. 2017 Sep;94:70-77. doi: 10.1016/j.ejrad.2017.06.007. Epub 2017 Jun 12.

29.

The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study.

Jujo-Sanada T, Tanabe N, Sakao S, Sugiura T, Sekine A, Nishimura R, Suda R, Naito A, Miwa H, Yamamoto K, Sasaki A, Matsumura A, Ema R, Kasai H, Kato F, Tatsumi K.

Pulm Circ. 2017 Jul-Sep;7(3):684-691. doi: 10.1177/2045893217717258. Epub 2017 Jun 12.

30.

The Development of Marked Collateral Circulation due to Inferior Vena Cava Filter Occlusion in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated with Anti-phospholipid Syndrome.

Kasai H, Tanabe N, Koshikawa K, Hirasawa Y, Sugiura T, Sakao S, Tatsumi K.

Intern Med. 2017;56(8):931-936. doi: 10.2169/internalmedicine.56.7599. Epub 2017 Apr 15.

31.

Adult Partial Anomalous Pulmonary Venous Connection With Drainage to Left Atrium and Inferior Vena Cava Clearly Visualized on a Combination of Multiple Imaging Techniques.

Kasai H, Sugiura T, Arano T, Shoji H, Jujo T, Sakao S, Tanabe N, Tatsumi K.

Circ J. 2017 Sep 25;81(10):1547-1549. doi: 10.1253/circj.CJ-17-0029. Epub 2017 Mar 31. No abstract available.

32.

Circulating Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies as a Potential Biomarker for Cardiovascular and Cerebrovascular Events in Patients with Obstructive Sleep Apnea.

Matsumura T, Terada J, Kinoshita T, Sakurai Y, Yahaba M, Ema R, Amata A, Sakao S, Nagashima K, Tatsumi K, Hiwasa T.

J Clin Sleep Med. 2017 Mar 15;13(3):393-400. doi: 10.5664/jcsm.6488.

33.

Prognostic and pathophysiological marker for patients with chronic thromboembolic pulmonary hypertension: Usefulness of diffusing capacity for carbon monoxide at diagnosis.

Suda R, Tanabe N, Ishida K, Kato F, Urushibara T, Sekine A, Nishimura R, Jujo T, Sugiura T, Shigeta A, Sakao S, Tatsumi K.

Respirology. 2017 Jan;22(1):179-186. doi: 10.1111/resp.12883. Epub 2016 Sep 11.

PMID:
27614712
34.

Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.

Jujo T, Tanabe N, Sakao S, Ishibashi-Ueda H, Ishida K, Naito A, Kato F, Takeuchi T, Sekine A, Nishimura R, Sugiura T, Shigeta A, Masuda M, Tatsumi K.

PLoS One. 2016 Aug 29;11(8):e0161827. doi: 10.1371/journal.pone.0161827. eCollection 2016.

35.

Right ventricular sugars and fats in chronic thromboembolic pulmonary hypertension.

Sakao S, Daimon M, Voelkel NF, Miyauchi H, Jujo T, Sugiura T, Ishida K, Tanabe N, Kobayashi Y, Tatsumi K.

Int J Cardiol. 2016 Sep 15;219:143-9. doi: 10.1016/j.ijcard.2016.06.010. Epub 2016 Jun 15.

PMID:
27323340
36.

Moyamoya disease and artery tortuosity as rare phenotypes in a patient with an elastin mutation.

Ishiwata T, Tanabe N, Shigeta A, Yokota H, Tsushima K, Terada J, Sakao S, Morisaki H, Morisaki T, Tatsumi K.

Am J Med Genet A. 2016 Jul;170(7):1924-7. doi: 10.1002/ajmg.a.37662. Epub 2016 Apr 15.

PMID:
27080061
37.

Prominin-1/CD133 expression as potential tissue-resident vascular endothelial progenitor cells in the pulmonary circulation.

Sekine A, Nishiwaki T, Nishimura R, Kawasaki T, Urushibara T, Suda R, Suzuki T, Takayanagi S, Terada J, Sakao S, Tada Y, Iwama A, Tatsumi K.

Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1130-42. doi: 10.1152/ajplung.00375.2014. Epub 2016 Apr 8.

38.

Pulmonary haemodynamics are correlated with intimal lesions in a rat model of severe PAH: attenuation of pulmonary vascular remodelling with ambrisentan.

Takeuchi T, Sakao S, Kato F, Naito A, Jujo T, Yasuda T, Tanabe N, Tatsumi K.

Histol Histopathol. 2016 Dec;31(12):1357-65. doi: 10.14670/HH-11-764. Epub 2016 Apr 6.

PMID:
27048555
39.

Mean Pulmonary Artery Pressure Using Echocardiography in Chronic Thromboembolic Pulmonary Hypertension.

Kasai H, Matsumura A, Sugiura T, Shigeta A, Tanabe N, Yamamoto K, Miwa H, Ema R, Sakao S, Tatsumi K.

Circ J. 2016 Apr 25;80(5):1259-64. doi: 10.1253/circj.CJ-15-1080. Epub 2016 Mar 11.

40.

Coagulation-Fibrinolysis System and Postoperative Outcomes of Patients With Chronic Thromboembolic Pulmonary Hypertension.

Kato F, Tanabe N, Ishida K, Suda R, Sekine A, Nishimura R, Jujo T, Sugiura T, Sakao S, Tatsumi K.

Circ J. 2016;80(4):970-9. doi: 10.1253/circj.CJ-15-1208. Epub 2016 Feb 16.

41.

Synergistic Effects of ACE Insertion/Deletion and GNB3 C825T Polymorphisms on the Efficacy of PDE-5 Inhibitor in Patients with Pulmonary Hypertension.

Nishimura R, Tanabe N, Sekine A, Kasai H, Suda R, Kato F, Jujo T, Sugiura T, Shigeta A, Sakao S, Tatsumi K.

Respiration. 2016;91(2):132-40. doi: 10.1159/000443772. Epub 2016 Jan 28.

42.

Importance of carefully interpreting computed tomography images to detect partial anomalous pulmonary venous return.

Jujo T, Tanabe N, Sugiura T, Naito A, Shigeta A, Kitazono-Saitoh M, Sakao S, Tatsumi K.

Respir Investig. 2016 Jan;54(1):69-74. doi: 10.1016/j.resinv.2015.08.008. Epub 2015 Oct 20.

PMID:
26718147
43.

Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.

Abe M, Tsushima K, Matsumura T, Ishiwata T, Ichimura Y, Ikari J, Terada J, Tada Y, Sakao S, Tanabe N, Tatsumi K.

Drug Des Devel Ther. 2015 Oct 23;9:5755-62. doi: 10.2147/DDDT.S90739. eCollection 2015.

44.

Effects of Surgical and Medical Treatment on Quality of Life for Patients With Chronic Thromboembolic Pulmonary Hypertension.

Urushibara T, Tanabe N, Suda R, Kato F, Kasai H, Takeuchi T, Sekine A, Nishimura R, Jujo T, Sugiura T, Shigeta A, Sakao S, Kasahara Y, Tatsumi K.

Circ J. 2015;79(12):2696-702. doi: 10.1253/circj.CJ-15-0538. Epub 2015 Oct 15.

45.

Increased Right Ventricular Fatty Acid Accumulation in Chronic Thromboembolic Pulmonary Hypertension.

Sakao S, Miyauchi H, Voelkel NF, Sugiura T, Tanabe N, Kobayashi Y, Tatsumi K.

Ann Am Thorac Soc. 2015 Oct;12(10):1465-72. doi: 10.1513/AnnalsATS.201504-236LE.

PMID:
26356218
46.

Correction: Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance.

Jujo T, Sakao S, Ishibashi-Ueda H, Ishida K, Naito A, Sugiura T, Shigeta A, Tanabe N, Masuda M, Tatsumi K.

PLoS One. 2015 Sep 8;10(9):e0138040. doi: 10.1371/journal.pone.0138040. eCollection 2015.

47.

Noninvasive assessment of pulmonary vascular resistance by echocardiography in chronic thromboembolic pulmonary hypertension.

Kasai H, Matsumura A, Sugiura T, Shigeta A, Tanabe N, Ema R, Sakurai Y, Yahaba M, Matsuura Y, Kawata N, Sakao S, Tatsumi K.

Respir Investig. 2015 Sep;53(5):210-6. doi: 10.1016/j.resinv.2015.03.002. Epub 2015 Jun 1.

PMID:
26344610
48.

Estimation using the impulse oscillation system in patients with pulmonary sarcoidosis.

Suzuki T, Tsushima K, Kawata N, Matsumura T, Matsuura Y, Ichimura Y, Terada J, Sakao S, Tada Y, Tanabe N, Tatsumi K.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jul 22;32(2):144-50.

PMID:
26278694
49.

Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance.

Jujo T, Sakao S, Ishibashi-Ueda H, Ishida K, Naito A, Sugiura T, Shigeta A, Tanabe N, Masuda M, Tatsumi K.

PLoS One. 2015 Aug 7;10(8):e0133167. doi: 10.1371/journal.pone.0133167. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0138040.

50.

Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension.

Sakao S, Voelkel NF, Tanabe N, Tatsumi K.

Respir Res. 2015 Jul 8;16:84. doi: 10.1186/s12931-015-0246-y. Review.

Supplemental Content

Support Center